Pro Medicus
Pro Medicus Limited is an Australian healthcare informatics company providing imaging software and clinical desktop solutions to the global radiology market. The company develops and markets Visage 7, an enterprise imaging software platform delivering rapid 3D visualization, archive management, and clinical workflow tools. Principal revenue drivers consist of recurring transaction-based software licensing fees, cloud image processing subscriptions, and professional implementation and support services. Pro Medicus serves major hospital networks, private radiology groups, academic medical centers, and outpatient imaging clinics primarily across North America, Europe, and Australia. The enterprise holds a market-leading position in high-performance cloud-native enterprise imaging software platforms. Pro Medicus Limited is headquartered in Richmond, Australia, and its common shares are listed on the Australian Securities Exchange.
20 of the funds FundTelligence covers report a position in Pro Medicus.
- Legal name
- Pro Medicus Ltd
- Sector
- Health Care
- Country
- Australia
- Funds holding it
- 20
Funds holding Pro Medicus
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.77 % (full portfolio disclosed, October 2026)
- Lannebo Marknad Pacific — Lannebo · 0.51 % (full portfolio disclosed, June 2026)
- Danske Invest Index Pacific incl. Canada ex. Japan Restricted — Danske Invest · 0.14 % (full portfolio disclosed, July 2026)
- KLP AksjeAsia Indeks — KLP · 0.11 % (full portfolio disclosed, June 2026)
- KLP Global Kvalitet Indeks — KLP · 0.04 % (full portfolio disclosed, June 2026)
- BlackRock iShares MSCI World Health Care Sector ESG UCITS ETF — BlackRock · 0.04 % (full portfolio disclosed, October 2026)
- Lannebo Marknad Global — Lannebo · 0.02 % (full portfolio disclosed, June 2026)
- Nordea World Passive — Nordea Funds · 0.01 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 20 funds holding it.